AMSTERDAM, the Netherlands, Nov. 12, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that its management will present at the Jefferies 2015 Global Healthcare Conference – London, to be held November 18-19, 2015.
Date: November 19, 2015
Time: 4:00 p.m. (GMT)
Speaking for uniQure: Jörn Aldag, Chief Executive Officer
To access a simultaneous webcast of Mr. Aldag's presentation via the internet, log on to the "Events" section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure's website for 30 days following the conference. Mr. Aldag's presentation will be available for download in PDF format immediately following the conference presentation in the "Events" section of the Media page of uniQure's website at http://www.uniqure.com/news/calendar-of-events/.
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com
CONTACT: uniQure: Aicha Diba Investor Relations Direct : +31 20 240 6100 Main: +31 20 566 7394 a.diba@uniQure.com Media inquiries: Gretchen Schweitzer MacDougall Biomedical Communications Direct: +49 172 861 8540 Main: +49 89 2424 3494 or +1 781 235 3060 email@example.comSource: uniQure